Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2024-05-31 | 2024-07-05 | 229427 |
| APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2024-08-01 | 2024-08-23 | 234277 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2024-08-09 | 2024-08-23 | 234996 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2024-09-12 | 2024-11-15 | 237348 |
| APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2019-01-03 | 2019-06-24 | 71151 |
| APO-VARENICLINE | 0.5MG 1MG | KIT TABLET | Resolved | 2019-02-05 | 2019-11-18 | 74839 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2019-02-06 | 2019-06-24 | 74935 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-04-18 | 2019-05-21 | 82022 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-12 | 2022-05-16 | 86341 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-12 | 2019-07-02 | 86347 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-12 | 2019-06-24 | 86364 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-07-17 | 2020-07-10 | 89554 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-07-17 | 2019-11-25 | 89557 |
| APO-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2022-12-16 | 2023-08-18 | 178766 |
| APO-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2023-04-21 | 2023-09-01 | 189999 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2023-05-12 | 2023-09-01 | 192361 |
| APO-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2023-06-09 | 2023-08-18 | 194581 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-09-18 | 2019-11-16 | 94203 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-11-20 | 2019-11-25 | 99320 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-01-22 | 2020-09-14 | 103926 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |